News

Navin Fluorine International has allotted 37,385 equity shares under ESOS on 21 April 2026. Consequently, the paid up equity share capital has increased to Rs 10,25,63,858/- consisting of 5,12,77,899 fully paid equity shares of face value of Rs 2/- each and 8,060 partly paid equity shares of face value Rs 2/- each, on which Re 1/- per share is paid.

Navin Fluorine International will hold a meeting of the Board of Directors of the Company on 29 April 2026.Powered by Capital Market - Live News

Net profit of Navin Fluorine International rose 121.77% to Rs 185.40 crore in the quarter ended December 2025 as against Rs 83.60 crore during the previous quarter ended December 2024. Sales rose 47.21% to Rs 892.37 crore in the quarter ended December 2025 as against Rs 606.20 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales892.37606.20 47 OPM %34.4724.30 - PBDT294.89137.58 114 PBT258.73108.02 140 NP185.4083.60 122 Powered by Capital Market - Live News

Navin Fluorine International has allotted 6,000 equity shares under ESOS on 05 February 2026. Considering this allotment, the paid-up share capital of the Company has increased to Rs 10,24,89,088/- consisting of 5,12,40,514 fully paid equity shares of face value of Rs 2/- each and 8,060 partly paid equity shares of face value Rs 2/- each, on which Re 1/- per share is paid. Powered by Capital Market - Live News

Navin Fluorine International announced that post the successful validation of batches by its European partner, commercial production at Phase 1 of cGMP-4 plant at Dewas has commenced today. Powered by Capital Market - Live News